Q1 FY2026 · Press release
September 17, 2025 · 36 pages
Read Roivant Sciences Ltd.'s results firsthand
Preview the first 2 pages of this press release
Create a free account to start reading
Full documents are included with Professional
Roivant Sciences Ltd.
38.23
USD
+2.19
(+6.08%)
Roivant Sciences Ltd. Documents
Q1 FY2026 documents
Earnings release
9 pages
Aug 11, 2025
Quarterly report
154 pages
Aug 11, 2025
Presentation
Brepo VALOR TLR_vFF
32 pages
Presentation
2025 June 30 10-Q_vFF
25 pages
Presentation
ROIV IMVT Graves Remission Data_vF
23 pages
Press release
36 pages
Sep 17, 2025
Press release
Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients _ Roivant Sciences Ltd_
5 pages
Sep 3, 2025